Skip to main navigation Skip to search Skip to main content

Open-Label Comparative Clinical Study of Chlorproguanil-Dapsone Fixed Dose Combination (Lapdap™) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria

  • Daniel G. Wootton
  • , Hyginus Opara
  • , Giancarlo Biagini
  • , Maxwell K. Kanjala
  • , Stephan Duparc
  • , Paula L. Kirby
  • , Mary Woessner
  • , Colin Neate
  • , Maggie Nyirenda
  • , Hannah Blencowe
  • , Queen Dube-Mbeye
  • , Thomas Kanyok
  • , Steve Ward
  • , Malcolm Molyneux
  • , Sam Dunyo
  • , Peter A. Winstanley
  • University of Liverpool
  • University of Malawi
  • Medical Research Council Laboratories Gambia
  • GlaxoSmithKline
  • Kamuzu University of Health Sciences
  • Gates Foundation
  • World Bank
  • Liverpool School of Tropical Medicine

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Open-Label Comparative Clinical Study of Chlorproguanil-Dapsone Fixed Dose Combination (Lapdap™) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science